TCL Archive NCI Plans To Issue Frederick Operations Contract As Sole-Source To SAIC-Frederick Inc. For Up To 10 Years. November 10, 2006
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: New Mount Sinai Cancer Center Gets $7 Million; Jules Harris Named Rush Cancer Center Director July 25, 1986
TCL Archive Karkin, Hatfield Vow to Amend Health Reform To Include Trust Fund For Medical Research June 4, 1993